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The field of human genomics has led advances in the
sharing of data with a view to facilitating translation of
research into innovations for human health. This change
in scientific practice has been implemented through new
policy developed by many principal investigators, project
managers and funders, which has ultimately led to new
forms of practice and innovative governance models for
data sharing. Here, we examine the development of the
governance of data sharing in genomics, and explore
some of the key challenges associated with the design
and implementation of these policies. We examine how
the incremental nature of policy design, the perennial
problem of consent, the gridlock caused by multiple and
overlapping access systems, the administrative burden
and the problems with incentives and acknowledgment
all have an impact on the potential for data sharing to be
maximized. We conclude by proposing ways in which
the scientific community can address these problems, to
improve the sustainability of data sharing into the future.the key challenges that are associated with the developmentIntroduction
Genomics research has led the scientific community in
implementing the principle of open access to enable wide-
scale sharing of data derived from human beings [1]. A
number of key documents relating specifically to genomics
research have established the principle of open access [2-4],
which has affected every aspect of genomic science, from
recruitment of research participants through to the publish-
ing of research results. The rationale behind these policies
is that research results and data generated through public
funding should be freely available to the wider research
community, to realize their full benefit. The National
Institutes of Health (NIH) considers that data sharing “is
essential to facilitate the translation of research results into* Correspondence: jane.kaye@law.ox.ac.uk
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health” [5]. To implement these data sharing principles,
new policy has been developed by many principal investiga-
tors, project managers and funders, which has ultimately
led to new forms of practice and innovative governance
models for data sharing, from projects such as the
Wellcome Trust Case Control Consortium (WTCCC) to
the innovative Personal Genome Project, which uses the
principle of open consent [6-8].
As data sharing in genomics research involving human
subjects has been carried out now for a number of years,
reconsideration of the issues arising from design and imple-
mentation of data access policies is timely and appropriate.
The NIH has recognized the need to revise and update its
data sharing policy [2]. Groups such as the Global Alliance
are exploring how to enable data sharing through various
initiatives, including better harmonization, creation of stan-
dards and development of incentives [2,3]. Here, we explore
some of the important issues associated with the design
and implementation of data sharing policies. In particular,
we focus on the processes used by scientists and some of
and implementation of data access policies. We examine
the implications of existing policy design mechanisms,
which often involve incremental approaches that build on
previous best practice, for the long-term sustainability of
data sharing of genomics research involving human
subjects, and we propose ways in which policy design can
be streamlined and improved to maximize the potential
benefits of data sharing for the genomics and biomedical
research communities.The history of data access policies
The Human Genome Project (HGP) was a significant
moment in the history of human genomics, because it
endorsed the principle that all sequencing data would be
deposited on the web to be immediately accessible by the
research community [4]. This decision built on the success
of practices that had been established in a number of other
molecular biology projects such as the PDB database forentral Ltd. The licensee has exclusive rights to distribute this article, in any
ion. After this time, the article is available under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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sequences [10]. The C. elegans genome project [11] estab-
lished important precedents in the coordination and
organization of specialist teams focused on the sequencing
of one organism. The first policy in human genomics
for pre-publication sequence data was described in the
Bermuda Principles (1996), which embodied the open
access approach taken in the HGP [12]. This was followed
by the Fort Lauderdale Agreement in 2003 [13] and the
Toronto Statement in 2009 [14], both of which further
endorsed the principle of rapid data release through the
web for sequence data. These principles were applied in
other projects that were established to set up sequence ref-
erence databases such as the HapMap Project (2002–2009)
[15] and the 1000 Genomes Project (2008–2012) [16].
After the HGP, new research approaches, such as
genome-wide association studies (GWAS) were used to
further understand the influence of genomes on disease. To
facilitate this approach, projects were established with the
support of funders to generate and compare the sequence
data drawn from samples collected by clinically based
researchers, usually as part of specific disease studies.
Examples of such projects are the WTCCC [7], Genetic
Association Information Network [17] and Database of
Genotypes and Phenotypes (dbGaP) [18], which were data-
generating projects as well as providing lasting community
resources. As part of these projects, new governance struc-
tures were developed so that the rest of the research
community could access the GWAS sequence data and
phenotypic data that had been generated by specific princi-
pal investigators (PIs). Data access committees (DACs)
were established to manage access requests but also to con-
sult and defer to PIs if necessary. The aim of this ‘managed
access’ model was to protect the interests of the partici-
pants who had donated the samples as well as the PIs, who
were responsible for the recruitment of patients and were
the custodians of the samples. This was a very different
model from the one that had been developed for the HGP
and subsequent GWAS data-generating projects.
One of the key lessons learnt from the GWAS initiatives
was that the open access web approach to sequence data
that had been a feature of the HGP was no longer feasible
if the confidentiality commitments that had been made to
research participants were to be upheld. Many of the
GWAS repositories had placed summary sequence data on
the web so that researchers could see this data before
applying through the managed access system to access add-
itional datasets or to collaborate with PIs. However, when it
was demonstrated that individuals could be distinguished
from aggregated single nucleotide polymorphism data [19],
the freely available summary GWAS data was withdrawn
and placed under managed access controls. This has
resulted in researchers now having to apply to access all
data through the managed access system, which requires aformal application stating the researchers’ credentials and
research proposal followed by approval from the DAC.
Concerns about the privacy risks for participants and the
linkage of sequence data to phenotypic data have meant
that ‘managed access’ repositories have become the norm,
as they allow data to be released to other researchers while
maintaining responsible scientific practice [20]. This is now
the most common form of governance for projects and
large consortia.
A significant feature of data access policies is that they
have been developed with the broad participation of many
stakeholders in the research community. Since the HGP, the
culture of openness has resulted in policies being developed
for opening up other health datasets for public health
purposes [21] and making publications open access [22].
Central repositories have been established for sequence data
such as the US dbGaP [23] and the European Genome-
phenome Archive (EGA) [24]. By starting to make data
sharing a condition of funding support, but also providing
repositories for the deposition of data, funders have worked
with the scientific community to further the open access
agenda [25]. One of the challenges has been how to inter-
pret the broad aspirations found in policy documents into
practical governance mechanisms that can guide day-to-day
scientific research. As Pryor [26] observes about funders’
policies in the UK, “unfortunately, none of them provides
explicit guidance in this matter, although generally they
acknowledge that different approaches to data sharing will
be required in different situations, making it appropriate for
researchers to determine their own strategies for data
sharing.” A common approach of funders’ policies is not to
prescribe how data should be shared, but rather require that
researchers have a plan for doing so [27]. Such an approach
respects the expertise of PIs and the diversity of practice that
exists across different scientific fields but places considerable
responsibility on researchers to develop a suitable govern-
ance structure to enable the sharing of data.Policy design - incremental policy development
One of the challenges in implementing an open access pol-
icy is identifying the governance structures and procedures
that are needed. For many researchers, the first step is
examining the policies of similar projects or consulting with
leaders in the field who have designed or implemented data
sharing systems [28]. Several repositories have led the field
in designing policies for purpose-built managed access
databases, such as dbGaP and the EGA. Large projects have
also provided templates for consortia, such as the WTCCC
[29], the International Cancer Genome Consortium [30]
and MalariaGEN [31]. All of these projects have had a dedi-
cated team of ethicists, lawyers and people experienced in
policy development to focus on the development of the
data access elements of the project. A feature of these
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are pivotal in assessing applications to access datasets.
The governance structures of these first projects have
become the template for the projects and large consortia
that follow. There are both benefits and drawbacks to this
incremental approach that builds on previous best practice.
Using previous protocols or established methodologies
saves time because there is already a tried and tested proof
of principle. In addition, these policies have a stamp of
approval and a certain amount of credibility as they have
often been reviewed by an external body, such as a research
ethics committee. An important advantage of using such
‘off-the-peg’ governance systems is that they provide a
practical and efficient solution for scientists under time
pressures to design a workable process. It allows rapid
dissemination of practical experience and permits the diffu-
sion of the effective elements of policies. However, off-the-
peg governance systems are not necessarily appropriate for
all situations. This is because some projects can require
specific solutions, with generic clauses not fitting with the
circumstances of all projects. For example, if a project
includes samples collected from participants in the devel-
oping world, an off-the-peg governance system developed
in the USA or Europe will not include the specific provi-
sions that will probably be necessary to accommodate
differing models of consent, or that provide appropriate
protection for participants facing different risks [32].
A further concern is that the process described above can
result in an uncritical adoption of existing practice in the
field, rather than appropriate deliberation as to what should
be best practice for the field as a whole. Although it is
perfectly understandable that policy is designed in this way,
the dangers are that the policies, procedures and practices
that develop may not always be coherent when they are put
together as part of a broader meta-governance. To facilitate
global data sharing, funders and other stakeholders need to
move from concern for national priorities to the develop-
ment of a global data sharing and access system that is
streamlined and coordinated. Such a structure could exped-
ite access to a number of similar datasets at once wherever
they were located in the world. A challenge of such a
system would be ensuring that custodians of datasets were
consulted about potential uses of the data.
Access requirements
Currently, governance structures and the requirements for
access to data are designed around projects rather than the
type of data, which means that the same governance struc-
tures are being applied to all data. Having the same system
of approval for all datasets does not recognize that the risks
of disclosure or harm will vary with different datasets. Some
data may have lower risks of identifiability for the partici-
pants involved, and may be less sensitive. For example, pro-
jects that could potentially result in the identification ofindividuals and allow the inference of information about
sexual health might require higher levels of scrutiny than
other projects. Having differing levels of DAC oversight
proportionate to risks involved in using some datasets may
be more appropriate.
Although it may be important that the specific require-
ments of individual projects be managed through access
regimes designed to fit those projects, when the access sys-
tems for individual projects are put together, they may have
the cumulative effect of slowing down access to data. The
requirement for separate applications to individual projects
each time data is needed not only causes delay and involves
additional costs for research activities but is also an obstacle
to the long-term sustainability of data sharing. If data users
need to access data from a large number of projects and
there are separate systems of access for each of these
projects, with slightly different requirements and forms for
each, data users will be faced with an effective gridlock. For
example, the criteria on which an application is assessed by
a DAC can vary between projects, but also between juris-
dictions. In cases in which multiple datasets are needed,
only some researchers will have the means to access the
data required to carry out the highest quality research, be-
cause of the significant burdens in terms of administrative
effort of data access applications.
Considering that the purpose of data sharing is to
maximize data usage [33], this potential gridlock problem
constitutes a significant obstacle to sustainability. It could be
addressed proactively through better triaging of the risks
associated with using different types of data, to minimize
the burdens of access (particularly for aggregated data), and
ensuring global, coordinated systems of access. Institutional
agreements that cover all access requests to a dataset by all
researchers in an institution are needed to supplement over-
sight by DACs. Such institutional agreements are common
with digital library resources and archives and, although the
two types of resources are quite different, the agreements
may provide a model for systems of access. The research
community needs to work towards global meta-governance
solutions to cut down on bureaucracy and to support
research that requires data from a number of sources.
Consent
The lack of appropriate consent from research participants
has sometimes been a barrier to sharing data. This is
because obtaining consent prior to research participation is
a fundamental requirement for ethical and lawful research
practice. Informed consent is therefore one of the major
protections in place for participants and has become the
framework that determines whether data on human subjects
can be distributed and accessed for further research. The
signed informed consent form has become the record of
what participants have agreed to, and if this does not
mention that data will be shared with other researchers,
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data sharing will not be possible. Until recently, many
projects did not ask for consent for data sharing, unless they
were projects such as the HapMap Project and the 1000
Genomes Project, whose consent forms stipulated that all
data would be openly distributed on the internet. The
difficulty has been for projects that have been carried out at
a time when wide-scale data sharing was not envisaged.
In such cases, it is usually the researchers who make the
initial judgment as to whether the scope of the consent
covers data sharing and whether the matter should be
referred to another decision maker for consideration. This
dilemma can place researchers in a difficult position, as
they have drafted the consent form in the first place, and it
would be tempting to interpret the scope of the consent
rather broadly, especially as contacting participants to gain
additional consent (‘re-consenting’) can be a costly and
time-consuming task that may also inconvenience research
participants unnecessarily. With the current paper-based
consent process, which is locked in time at the beginning
of the research process, it is very difficult to ‘future-proof ’
consent forms to cover every eventuality. As a solution, a
broad consent to data sharing has often been obtained,
which leads to the invidious situation that research partici-
pants are not informed about all the uses of their data
because this is impossible at the time of recruitment. More-
over, such broad consent is contrary to privacy and data
protection principles developed in many countries. To
address these concerns, new online dynamic consent com-
munication portals are being developed to enable research
participants to receive information about research and to
give consent to the use of their personal information for
different purposes as it moves through networks [34-36].
If consent forms do not explicitly mention data sharing,
referral is usually made to independent review boards,
research ethics committees, DACs or in some cases a
patient group for deliberation. In such situations, decision-
making committees are heavily dependent on the wording
of the consent form. Deliberations can become formalistic
as the context of consent is necessarily stripped away, and
whether data sharing is permitted under the original
consent is construed as a black/white, yes/no issue. Some
committees may use a more inclusive view of respect for
consent, which may pay some attention to the ‘spirit’ of the
consent, often as interpreted by the original PI. The risk of
such an approach is that it may be too loose when there is
a strong impetus to use the data in a way that does not
respect the wording of the consent. For example, when
participants gave consent to research only for a particular
disease, use of their samples as controls for research into
another unrelated disease is use that is inconsistent with a
formal interpretation of the original consent. However, this
might be seen to be consistent with the ‘spirit’ of consent,
or justified by the need for samples for this type of research.Although it is not a use that is consistent with the formal
wording of the original consent of the participants, it may
be in conformity with the views of participants if they were
asked.
Although there are differences in approach between juris-
dictions and committees, common factors are that such
deliberations can require considerable time, and decision-
making is placed in the hands of experts rather than in the
hands of the research participants themselves. Until a tran-
sition is made to electronic forms of governance, the paper
informed consent form remains the primary record of what
participants have consented to and re-consenting will con-
tinue to be costly and time-consuming. The benefits of the
dynamic consent system is that it allows multiple different
consents to be presented to participants through an online
portal, ranging from a broad consent for specific classes of
research to an explicit consent for clinical trials. Such a
system provides an efficient way to re-contact individuals
and to communicate and engage with them, so that they
can make decisions about the use of their data in real time.
The dynamic consent model provides the means to obtain
consent for the use of data as it is shared in different
research networks in an ethical and lawful manner.
New forms of acknowledgement
When designing new governance systems for sharing data
there are various considerations that policy makers and
researchers need to take into account (Box 1). Protecting
the interests of participants has always been the foremost
concern of researchers, regulators and policy makers, but
the desire to share data and the need to protect privacy
have often been characterized as two binary opposites, with
privacy being a barrier to sharing. This has tended to
obscure other concerns. It has become apparent that there
are other areas of tension, such as appropriate recognition
of data generators [6] and how to ensure fair access to
resources [37], which are outside the traditional domain of
research ethics but are just as important to the success of
data sharing. To deal with these issues, new procedures and
governance structures have been developed to acknowledge
and reward essential activities.
Currently, career metrics, which affect hiring, tenure and
assessments of research productivity, are orientated around
publications rather than the creation of datasets for use by
other researchers [38]. Although funders consider that data
sharing increases the benefits that have been made to the
public in research [39] and researchers can see the benefit
of sharing some kinds of data [40], there are also disadvan-
tages to implementing data sharing policies. The following
quotes illustrate this: “disincentives to sharing research data
include lack of reward or credit for sharing, the substantial
amount of labor required to document data in reusable
forms, concerns for misuse or misinterpretation of data,
control over intellectual property, and the need to restrict
Box 1. Key challenges and corresponding solutions for sustainability of data sharing
Challenges of developing data sharing governance
• Data sharing is often required as a condition of funding but funders have not prescribed how this should be done. This has resulted in a
learning curve for researchers who have had to expend resources to archive datasets or, in the case of consortia, develop policy and
governance systems to oversee access to datasets.
• For consortia, developing policy and governance systems to share data are costly and time-consuming to establish, so the first projects often
become templates for the projects that follow.
• Current data access procedures and governance work well for individual projects, but their cumulative effect may result in access procedures
becoming cumbersome and disproportionate to the risks associated with using some datasets.
• Separate and uncoordinated approval systems to access project data are at risk of becoming unduly bureaucratic and undermining research
that requires data from a number of sources.
• New ways to reward data generators, such as through researcher IDs and the citation of resources in publications are in the process of
development but still need to be uniformly recognized and implemented.
Solutions to ensure sustainability of data sharing
• Further research needs to be undertaken to understand the reasons for the sizeable differences in access rates between open access models
and managed access models for data sharing.
• There needs to be appropriate ethical and legal support and expertise for those who are developing initial policies as these become the
templates for further studies. Funders need to ensure that large projects have this support.
• Greater attention and appropriate funding needs to be given to the cost associated with managing data sharing activities.
• Better systems of triaging need to be developed to ensure that appropriate access procedures and oversight mechanisms are proportionate to
the risks involved for access to different types of data.
• To ensure that access application systems are appropriately harmonized across the globe, funders could take the lead, informed by policy
developed through the ELSI 2.0 infrastructure, in implementing a system that is more proportionate for lower risk data.
• Accreditation and researcher IDs could be used as part of an electronic meta-governance system to promote international research.
• Further work is needed to develop meta-governance structures at a global level that are accountable, transparent and representative of all
stakeholders’ interests, but will also minimize bureaucracy and facilitate research.
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“researchers may feel that it is not worth collecting the data
in the first place, and that an easier path to publication, and
scientific glory, is simply to regularly request access to data
that colleagues have collected” [40]. As a way to deal with
these concerns, some DACs impose publication morator-
iums that give data generators a 6-month lead time to pub-
lish from the data before other researchers can have access
to it. Such moratoria can also be enforced by publications
committees and breaches have been dealt with effectively
[42,43]. As well as publication moratoria, technological
identifiers (IDs), such as Bioresource Research Impact
Factor for biobanks [44] and the Open Researcher and
Contributor ID [45], are forms of accreditation and
acknowledgement schemes that provide a means of allocat-
ing credit for data generation in novel ways. These schemes
help but do not in themselves completely address the
problem. The genomics community needs to continue to
develop novel means of allocating credit so that data gener-
ators and data users can be appropriately rewarded and
incentivized.Administrative burden
There is a broad consensus in the scientific community that
there is a need for managed access to most types of gen-
omic data [39]. However, deciding whether to enable access
to datasets involves deliberation and decision-making. A
significant concern for those responsible for managing
projects is the additional administrative load this creates.
The process of designing policies, implementing them and
administering applications for access are all considerable
burdens. This can be disproportionately onerous for smaller
and less well funded institutions and projects [41]. Often,
management of access falls to a small number of people in
a consortium who have the appropriate skills. For many
project managers in consortia where large datasets are
managed, data access can become a full time occupation.
These costs are largely hidden, but greater attention needs
to be given to the ongoing costs associated with managing
data sharing activities and ideally this needs to be factored
into grant applications.
Another concern is that the current administrative over-
sight of managed access systems based on DACs may be
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open access policies, many genomic datasets are firstly
managed by project DACs and when the project ends they
are deposited in the managed access archives such as
dbGaP and EGA. Despite the huge investment in develop-
ing these archives, the data deposited in them is accessed
and used relatively rarely compared with data deposited for
use on the internet, such as in the HapMap project [46,47].
Often, a system of triaging is used to cut down on the ap-
plications requiring review by a DAC. But despite this, a
large proportion of the assessment is carried out by these
committees on a case-by-case basis. In contrast, the num-
bers of researchers accessing open datasets on the internet
where there are no DACs is much higher than through
managed access systems [40]. Although it is anticipated that
in the future there will be more information technology
solutions, or e-governance tools, which will assist with the
expedition of review and the minimization of unnecessary
administrative burden electronically, currently this is not
the case [48]. Another suggestion for cutting down on
administration is “to implement an annual certification
process, which would grant the certified researcher unre-
stricted access to study results with the condition that the
data could only be used for research goals that do not
compromise the participants’ privacy” [49]. To make such a
system effective, resources would have to be put in to the
development of effective tracking systems that would
enable all of the uses of data to be monitored so that
inappropriate uses of the data could be sanctioned.Moving forward
Genomics has been a leader in the sharing of data, because
funders and researchers have endorsed the principle of
open access and put considerable resources and expertise
into the development of data sharing governance systems.
To reach this point has required commitment to the
curation and archiving of, and access to, datasets and the
development of new ways of working, which are now an
intrinsic part of the governance design and management
structures for new research. Leading projects have set the
standards and developed the systems that have been
adopted by later research projects. However, these have
been applied to individual projects, without a critical
appraisal of the implications for the field as a whole. This
incremental build-up of oversight systems may affect the
long-term sustainability of data sharing. Commentators
have argued that managed access datasets, which have
become the norm in genomics, have a chilling effect on
access requests to data. It is not clear whether this is
because of the type of data that is held in managed access
datasets, which may not be suitable for a broad range of
scientific uses, or whether it is because governance require-
ments are too restrictive.As descibed earlier, the difficulties of obtaining consent
for future, unforeseen uses and the resources needed to go
back for re-consent, if the original consent is inadequate,
are a significant stumbling block to streamlined lawful and
ethical data sharing. The current paper-based, up-front
systems of obtaining consent are inadequate for the flows
of data that are required for expedited data sharing. In the
current system, once consent is obtained, research partici-
pants, who are the subjects of the study and take privacy
risks, no longer have any control over the use of their data.
In contrast, the dynamic consent approach developed as
part of the ENCoRe project [50] uses information technol-
ogy to provide a way in which research participants can
become more engaged in how their personal information is
used in research. This approach, which can transcend
national boundaries, enables engagement with participants
to be more streamlined and effective [34].
The ways in which genomics data sharing policies have
been designed, and the strengths and weaknesses of the
incremental approach described earlier, give rise to some
important lessons for future policy development, both in
genomics and in other fields of scientific endeavour in
terms of sustainability (Box 1). It is clear that policies need
to have a normative foundation to ensure that robust and
coherent governance mechanisms are in place, not just in
large projects but also in smaller ones. Therefore, it is
essential that appropriate ethical and legal support and
expertise is available for those who are developing the initial
policies, as these become the templates for further studies.
This is also essential for the design of meta-governance
structures. In this respect, advice from experts on the
ground as well as the use of a broader policy-making
infrastructure will be essential to develop global meta-
governance structures. One such policy-making infrastruc-
ture is ELSI 2.0, which is an initiative designed to enable a
wide range of stakeholders to participate in global research
and policy activities [51].
The administrative burden of access is a key challenge,
not only for those developing and implementing policies,
but also for researchers who wish to either share or access
data. To address this challenge, better systems are needed
so that access procedures and oversight mechanisms are
proportionate to the risks involved for different types of
data. In considering the proportionality of oversight,
funders are ideally placed to drive the implementation of a
system that minimizes administrative burden while provid-
ing appropriate protection. In the longer term, meta-level,
global governance systems need to be developed, which
incorporate information technology or e-governance solu-
tions that can reward new types of contributions and cut
down on unnecessary administration.
With the launch of the Global Alliance that seeks to build
an infrastructure to share data with many researchers
across the world [2], and with many funders considering
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time to reflect on how data sharing policy has been devel-
oped and implemented. To make data sharing more effi-
cient, economic and effective at a global level requires the
development of a strategy that involves many stakeholders.
This strategy cannot be nationally based but must be orien-
tated to the needs of global research and be facilitated by
global infrastructure. Access requirements need to be orga-
nized around classes of data rather than being organized
around projects and studies. New web technologies need to
be used to deal with the complex issues around recruit-
ment, consent and citizen engagement. Incentives and
rewards for data generation and sharing need to be linked
with institutional career paths for researchers, particularly
in academia. Greater attention and support needs to be
given to the importance of incremental development of
practice as well as to the administrative load that data
sharing policy requires. The potential to use information
technologies to track the use of data and ensure compliance
with data sharing requirements still needs to be explored to
develop global data sharing.
For data sharing to persist as a key element of genomics
research, it is important that it be sustainable - that it
continues effectively and durably into the future with
appropriate oversight and protections for researchers and
participants while still allowing research to proceed. Sustain-
ability of data sharing is a complex issue and involves the
sustainability of many different facets of the system: the data
generation itself, the policies and procedures for sharing the
data, the researchers who use the shared data, and the infra-
structure that supports the enterprise [52]. Attention to the
development and design of new governance structures at
the project, consortia and global levels will go some way to
ensuring that data continues to be accessed efficiently to
achieve the aims of open access policies.
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